NCT01962454View on ClinicalTrials.gov

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 5, 2014

Primary Completion Date

March 20, 2015

Study Completion Date

March 20, 2015

Conditions
Cachexia
Interventions
DRUG

Deuterated Water

D2O 70% will be supplied as clear liquid, provided in 50 millilitre (mL) unit dose vials; administered per orally.

DRUG

Testosterone enanthate

Testosterone enanthate 125mg injection will be supplied as colorless to pale yellow liquid; administered intramuscular (IM).

DRUG

Placebo to match testosterone enanthate

Placebo to match testosterone enanthate 0.625 mL injection will be supplied as greenish yellow, bright and clear oily liquid; administered intramuscular (IM).

Trial Locations (1)

27705

GSK Investigational Site, Durham

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01962454 - A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter